SLC9A1

Chr 1AR

solute carrier family 9 member A1

Also known as: APNH, LIKNS, NHE-1, NHE1, PPP1R143

The protein is a plasma membrane sodium/hydrogen antiporter that maintains intracellular pH homeostasis and cell volume by exchanging intracellular protons for extracellular sodium ions. Mutations cause Lichtenstein-Knorr syndrome, which follows autosomal recessive inheritance. The gene shows high constraint against loss-of-function variants (LOEUF 0.375), indicating that heterozygous loss-of-function mutations are likely tolerated while biallelic variants cause disease.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 0.381 OMIM phenotype
Clinical SummarySLC9A1
🧬
Gene-Disease Validity (ClinGen)
Lichtenstein-Knorr syndrome · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.79) — some intolerance to loss-of-function variants.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint
0.38LOEUF
pLI 0.790
Z-score 4.22
OE 0.19 (0.100.38)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
3.55Z-score
OE missense 0.56 (0.510.62)
292 obs / 519.8 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.19 (0.100.38)
00.351.4
Missense OE0.56 (0.510.62)
00.61.4
Synonymous OE0.86
01.21.6
LoF obs/exp: 6 / 31.6Missense obs/exp: 292 / 519.8Syn Z: 1.66
DN
0.6453th %ile
GOF
0.74top 25%
LOF
0.4627th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

SLC9A1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →